Meeks Sanford L, Shah Amish P, Sood Gaurav, Dvorak Tomas, Zeidan Omar A, Meeks Dylan T, Kelly Patrick
Department of Radiation Oncology, Orlando Health UF Health Cancer Center, Orlando, FL.
JCO Oncol Pract. 2021 Dec;17(12):e1943-e1948. doi: 10.1200/OP.20.00495. Epub 2020 Nov 10.
An episode-based payment model, the Radiation Oncology Alternative Payment Model (RO-APM), has been proposed for Medicare reimbursement of radiation services provided to oncology patients. RO-APM may have significant impact on reimbursement for specific patient populations.
This investigation compares historical fee-for-service technical reimbursement estimates at a large hospital-based system to the RO-APM for advanced radiotherapy treatment of specific cancer types. These advanced techniques, stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), online-adaptive SBRT, and proton therapy, were specifically chosen because they are resource intensive and are correspondingly among the most expensive radiation oncology procedures. A total of 203 Medicare patients were analyzed.
RO-APM base-rate reimbursements were similar for SRS and were 38%-47% higher for SBRT. The proposed rates were 1%-31% lower for online-adaptive SBRT, and 48%-71% lower for proton therapy.
These data suggest that the RO-APM may have the desired effect of encouraging shorter courses of radiotherapy, such as SBRT. However, emerging technologies that require large capital and operating investments may see an overall significant reduction in proposed reimbursement.
已提出一种基于疗程的支付模式,即放射肿瘤学替代支付模式(RO - APM),用于医疗保险对肿瘤患者提供的放射治疗服务进行报销。RO - APM可能会对特定患者群体的报销产生重大影响。
本研究将一家大型医院系统中历史上按服务收费的技术报销估计与RO - APM针对特定癌症类型的先进放射治疗进行比较。这些先进技术,即立体定向放射外科(SRS)、立体定向体部放疗(SBRT)、在线自适应SBRT和质子治疗,被特意挑选出来,是因为它们资源密集,相应地也是放射肿瘤学中最昂贵的治疗程序。总共分析了203名医疗保险患者。
SRS的RO - APM基本费率报销相似,SBRT的报销高出38% - 47%。在线自适应SBRT的提议费率低1% - 31%,质子治疗的提议费率低48% - 71%。
这些数据表明,RO - APM可能会产生鼓励采用更短疗程放疗(如SBRT)的预期效果。然而,需要大量资本和运营投资的新兴技术可能会看到提议报销总体大幅减少。